The Role of Nuclear Factor κB in Pancreatic Cancer and the Clinical Applications of Targeted Therapy

Abstract:Pancreatic cancer is one of the leading causes of cancer mortality in the United States. Current therapy for pancreatic cancer involves surgery, chemotherapy, and radiation therapy; however, the 5-year survival rate remains less than 5%. New strategies for treating pancreatic cancer include